Alicanto Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 1.00 M
as on 12-12-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1165.42%
(FY 2023)
- Profit 276.28%
(FY 2023)
- Ebitda 153.64%
(FY 2023)
- Net Worth 313.72%
(FY 2023)
- Total Assets 144.09%
(FY 2023)
About Alicanto Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Naresh Arora and Atin Arora serve as directors at the Company.
- CIN/LLPIN
U24297HR2021PTC096192
- Company No.
096192
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alicanto Biotech Private Limited offer?
Alicanto Biotech Private Limited offers a wide range of products and services, including Dentist Tools, Equipment & Supplies, Oral Care Kit, Ayurvedic, Herbal Oils and Cosmetics, Herbal Cosmetics, Nutraceuticals & Dietary Supplements, Fitness Supplements, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Ayurvedic & Herbal Health Supplement, Herbal Juice.
Who are the key members and board of directors at Alicanto Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Arora  | Director | 08-Jul-2021 | Current |
| Atin Arora | Director | 08-Jul-2021 | Current |
Financial Performance of Alicanto Biotech.
Alicanto Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1165.42% increase. The company also saw a substantial improvement in profitability, with a 276.28% increase in profit. The company's net worth Soared by an impressive increase of 313.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alicanto Biotech?
Unlock access to Alicanto Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alicanto Biotech?
Alicanto Biotech has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alicanto Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alicanto Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
